XML 96 R77.htm IDEA: XBRL DOCUMENT v3.25.1
Derivative Instruments (Details) - USD ($)
$ in Millions
3 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Dec. 31, 2024
Mar. 31, 2022
Derivatives [Line Items]        
Unrealized Gain on Derivatives $ 16.6 $ 50.6    
Unrealized Loss on Derivatives (30.7) (0.3)    
Unrealized Gain (Loss) on Derivatives (14.1) 50.3    
Foreign Currency Cash Flow Hedge Gain (Loss) To Be Reclassified During Next 15 Months 14.1      
Foreign Currency Cash Flow Hedge Gain (Loss) to be Reclassified During Next 12 Months 13.4      
Gain (loss) on foreign currency derivative instruments not designated as hedging instruments $ (7.7) 24.3    
Minimum        
Derivatives [Line Items]        
Range of durations of foreign currency forward contracts 1 month   1 month  
Maximum        
Derivatives [Line Items]        
Range of durations of foreign currency forward contracts 15 months   12 months  
Not designated as hedging instrument        
Derivatives [Line Items]        
Derivative, Notional Amount $ 866.7   $ 738.7  
Other current assets | Designated as hedging instrument        
Derivatives [Line Items]        
Derivative asset, fair value 22.6   58.4  
Other current assets | Not designated as hedging instrument        
Derivatives [Line Items]        
Derivative asset, fair value 17.6   4.1  
Accrued expenses and other | Designated as hedging instrument        
Derivatives [Line Items]        
Derivative liability, fair value 28.8   0.3  
Accrued expenses and other | Not designated as hedging instrument        
Derivatives [Line Items]        
Derivative liability, fair value 3.7   11.4  
Foreign exchange contract | Designated as hedging instrument        
Derivatives [Line Items]        
Derivative, Notional Amount 1,927.9   1,235.0  
Cash Flow Hedging [Member] | Foreign exchange contract | Other long-term liabilities        
Derivatives [Line Items]        
Derivative liability, fair value 0.8   0.0  
Revenue | Foreign exchange contract        
Derivatives [Line Items]        
Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, before Tax 10.9 2.9    
Revenue | Cash flows, revenue | Foreign exchange contract        
Derivatives [Line Items]        
Gain on interest rate swap 0.4 0.2    
Operating expense | Foreign exchange contract        
Derivatives [Line Items]        
Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, before Tax 0.7 (2.1)    
Operating expense | Cash flows, operating expenses | Foreign exchange contract        
Derivatives [Line Items]        
Gain on interest rate swap (1.0) $ (1.2)    
Euro | Foreign exchange contract | Designated as hedging instrument        
Derivatives [Line Items]        
Derivative, Notional Amount 1,603.6   1,062.6  
Swiss franc | Foreign exchange contract | Designated as hedging instrument        
Derivatives [Line Items]        
Derivative, Notional Amount 102.5   133.8  
Japan, Yen | Foreign exchange contract | Designated as hedging instrument        
Derivatives [Line Items]        
Derivative, Notional Amount 30.2   38.6  
Canadian dollar | Foreign exchange contract | Designated as hedging instrument        
Derivatives [Line Items]        
Derivative, Notional Amount $ 191.6   $ 0.0  
Samsung Bioepis        
Derivatives [Line Items]        
Equity, ownership interest       49.90%